By Aliya Sternstein, A core Internal Revenue Service system for calculating Obamacare fees for health insurers and drug manufacturers has security weaknesses, according to an internal audit.

Under the Affordable Care Act, insurers must report their net premiums to the tax agency annually, and pharmaceutical companies must submit sales data from certain government programs.